The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
New research suggests that the way you eat—whether driven by emotions or external cues—can significantly influence how well GLP-1 medications like Ozempic, Wegovy, and Mounjaro work for weight loss and type 2 diabetes management. Learn what this means for your treatment.
Discover the science behind GLP-1 peptides, including semaglutide and tirzepatide, and their transformative impact on weight management and metabolic health. Learn about popular medications and how they're changing the landscape of health tracking.
Achieving sustainable weight loss is a journey, not a race. This comprehensive guide offers expert advice on nutrition, exercise, and mindset to help you build healthy habits for life.
Eli Lilly's monumental $4.5 billion investment in its Indiana facilities signals a significant ramp-up in production for groundbreaking GLP-1 agonists like Mounjaro and Zepbound, alongside future weight loss and cardiometabolic disease treatments. This expansion is poised to meet surging global demand and solidify Lilly's position at the forefront of pharmaceutical innovation.
A groundbreaking NIH-funded study reveals that emerging GLP-1 weight-loss drugs, including oral options like orforglipron, work by targeting a specific brain reward pathway, distinct from their appetite-suppressing effects. This discovery opens new avenues for understanding and treating conditions beyond weight management.
The massive adoption of GLP-1 receptor agonists for weight management is creating a significant ripple effect across the food industry, specifically driving an intense surge in demand for high-quality, muscle-preserving protein sources like whey. Dairy producers are scrambling to meet this new market reality.
New research suggests a connection between GLP-1 medications and temporary hair loss. Discover what this means for users of drugs like Ozempic, Wegovy, and Mounjaro, and how to navigate this common side effect.
A man's harrowing experience with extreme diarrhea after overdosing on an experimental GLP-1 drug, retatrutide, serves as a stark reminder of the risks associated with obtaining and using unapproved medications outside of medical supervision. This article delves into the case, the science behind these powerful weight loss drugs, and the importance of regulated healthcare.
Successfully losing weight with medications like Ozempic and Mounjaro is a significant achievement. However, the journey doesn't end there. This article explores how to maintain your progress and prevent weight regain after discontinuing these powerful GLP-1 receptor agonists.
